We can speculate that the increased soluble CD21 and soluble CD23 seen in CLL is likely a consequence of a positive feedback mechanism where soluble CD21 stimulates monocyte activation via CD23. The gene discussed is CR2; the disease is B-cell chronic lymphocytic leukemia.